Impact of creative art therapy on fatigue and quality of life in patients treated for localized breast cancer: A randomized study.

creative art therapy localized breast cancer quality of life randomized study severe fatigue

Journal

Psycho-oncology
ISSN: 1099-1611
Titre abrégé: Psychooncology
Pays: England
ID NLM: 9214524

Informations de publication

Date de publication:
08 2022
Historique:
revised: 12 03 2022
received: 10 12 2021
accepted: 14 04 2022
pubmed: 1 5 2022
medline: 10 8 2022
entrez: 30 4 2022
Statut: ppublish

Résumé

Art therapy (AT) as supportive care may help patients cope with cancer treatments. This non-blinded randomized trial assessed the impact of creative AT on severe fatigue and quality of life (QoL) in localized breast cancer patients undergoing irradiation. 320 patients were randomized to an AT group (ATG; 8 weekly sessions starting during irradiation) or to a standard group (SG). The primary endpoint was severe global fatigue (Functional Assessment of Chronic Therapy Fatigue subscale score <37) at 1 month post-irradiation. Quality of life (Fact-B), anxiety/depression (Hospital Anxiety and Depression Scale (HADS)) and different dimensions of fatigue 20-item Multidimensional Fatigue Inventory (MFI-20) were assessed at 1, 6 and 12 months post-irradiation. The secondary endpoints, fatigue among patients treated with chemotherapy, QoL (Fact-B), anxiety/depression (HADS) and different dimensions of fatigue (MFI-20) at 1, 6 and 12 months post-irradiation (with post hoc analysis in patients with treated with chemotherapy) were also assessed. 82% of patients completed ≥8 sessions. Severe initial global fatigue was observed in 43% of patients in each group, and among in 64% of patients whose treatment protocol contained chemotherapy. At 1 month post-irradiation, 45% in the ATG and 57% of patients in the SG reported severe global fatigue (p = 0.37); among patients with initial severe mental fatigue (MFF), 79% and 44% had improved MFF (p = 0.007) respectively; similarly 79% and 44% with initial poor motivation had better mental motivation (p = 0.03). At 6 and 12 months, social well-being scores in the ATG were higher (21.3 and 21.4 vs. 19.8 and 19.2, p = 0.05 and p < 0.01) with a significant improvement for patients who had chemotherapy (41% vs. 18%, p = 0.017). A positive association was observed between the number of AT sessions, fatigue and QoL (p < 0.01). AT did not significantly improve global severe fatigue among all cancer participants 1 month after radiation therapy, however it had a positive impact on social well-being and may improve MFF and motivation.

Sections du résumé

BACKGROUND
Art therapy (AT) as supportive care may help patients cope with cancer treatments. This non-blinded randomized trial assessed the impact of creative AT on severe fatigue and quality of life (QoL) in localized breast cancer patients undergoing irradiation.
MATERIAL AND METHODS
320 patients were randomized to an AT group (ATG; 8 weekly sessions starting during irradiation) or to a standard group (SG). The primary endpoint was severe global fatigue (Functional Assessment of Chronic Therapy Fatigue subscale score <37) at 1 month post-irradiation. Quality of life (Fact-B), anxiety/depression (Hospital Anxiety and Depression Scale (HADS)) and different dimensions of fatigue 20-item Multidimensional Fatigue Inventory (MFI-20) were assessed at 1, 6 and 12 months post-irradiation. The secondary endpoints, fatigue among patients treated with chemotherapy, QoL (Fact-B), anxiety/depression (HADS) and different dimensions of fatigue (MFI-20) at 1, 6 and 12 months post-irradiation (with post hoc analysis in patients with treated with chemotherapy) were also assessed.
RESULTS
82% of patients completed ≥8 sessions. Severe initial global fatigue was observed in 43% of patients in each group, and among in 64% of patients whose treatment protocol contained chemotherapy. At 1 month post-irradiation, 45% in the ATG and 57% of patients in the SG reported severe global fatigue (p = 0.37); among patients with initial severe mental fatigue (MFF), 79% and 44% had improved MFF (p = 0.007) respectively; similarly 79% and 44% with initial poor motivation had better mental motivation (p = 0.03). At 6 and 12 months, social well-being scores in the ATG were higher (21.3 and 21.4 vs. 19.8 and 19.2, p = 0.05 and p < 0.01) with a significant improvement for patients who had chemotherapy (41% vs. 18%, p = 0.017). A positive association was observed between the number of AT sessions, fatigue and QoL (p < 0.01).
CONCLUSION
AT did not significantly improve global severe fatigue among all cancer participants 1 month after radiation therapy, however it had a positive impact on social well-being and may improve MFF and motivation.

Identifiants

pubmed: 35488808
doi: 10.1002/pon.5940
doi:

Types de publication

Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1412-1419

Informations de copyright

© 2022 John Wiley & Sons Ltd.

Références

Noal S, Levy C, Hardouin A, et al. One-year longitudinal study of fatigue, cognitive functions, and quality of life after adjuvant radiotherapy for breast cancer. Int J Radiat Oncol Biol Phys. 2011;81(3):795-803. https://doi.org/10.1016/j.ijrobp.2010.06.037
Geinitz H, Zimmermann FB, Thamm R, Keller M, Busch R, Molls M. Fatigue in patients with adjuvant radiation therapy for breast cancer: long-term follow-up. J Cancer Res Clin Oncol. 2004;130(6):327-333. https://doi.org/10.1007/s00432-003-0540-9
Bower JE, Wiley J, Petersen L, Irwin MR, Cole SW, Ganz PA. Fatigue after breast cancer treatment: biobehavioral predictors of fatigue trajectories. Health Psychol Off J Div Health Psychol Am Psychol Assoc. 2018;37(11):1025-1034. https://doi.org/10.1037/hea0000652
Janaki MG, Kadam AR, Mukesh S, et al. Magnitude of fatigue in cancer patients receiving radiotherapy and its short term effect on quality of life. J Cancer Res Therapeut. 2010;6(1):22-26. https://doi.org/10.4103/0973-1482.63566
Bower JE. The role of neuro-immune interactions in cancer-related fatigue: biobehavioral risk factors and mechanisms. Cancer. 2019;125(3):353-364. https://doi.org/10.1002/cncr.31790
Greenlee H, DuPont-Reyes MJ, Balneaves LG, et al. Clinical practice guidelines on the evidence-based use of integrative therapies during and after breast cancer treatment: integrative Therapies during and after Breast Cancer Treatment. CA Cancer J Clin. 2017;67(3):194-232. https://doi.org/10.3322/caac.21397
Schuerger N, Klein E, Hapfelmeier A, Kiechle M, Brambs C, Paepke D. Evaluating the demand for integrative medicine practices in breast and gynecological cancer patients. Breast Care. 2019;14(1):35-40. https://doi.org/10.1159/000492235
Carlson LE, Zelinski E, Toivonen K, et al. Mind-body therapies in cancer: what is the latest evidence? Curr Oncol Rep. 2017;19(10):67. https://doi.org/10.1007/s11912-017-0626-1
Mustian KM, Alfano CM, Heckler C, et al. Comparison of pharmaceutical, psychological, and exercise treatments for cancer-related fatigue: a meta-analysis. JAMA Oncol 2017;3(7):961-968. https://doi.org/10.1001/jamaoncol.2016.6914
Lyman GH, Greenlee H, Bohlke K, et al. Integrative therapies during and after breast cancer treatment: ASCO endorsement of the SIO clinical practice guideline. J Clin Oncol. 2018;36(25):2647-2655. https://doi.org/10.1200/jco.2018.79.2721
Bosman JT, Bood ZM, Scherer-Rath M, et al. The effects of art therapy on anxiety, depression, and quality of life in adults with cancer: a systematic literature review. Support Care Cancer. 2021;29(5):2289-2298. https://doi.org/10.1007/s00520-020-05869-0
Tang Y, Fu F, Gao H, Shen L, Chi I, Bai Z. Art therapy for anxiety, depression, and fatigue in females with breast cancer: a systematic review. J Psychosoc Oncol. 2019;37(1):79-95. https://doi.org/10.1080/07347332.2018.1506855
Regev D, Cohen-Yatziv L. Effectiveness of art therapy with adult clients in 2018-what progress has been made? Front Psychol. 2018;9:1531. https://doi.org/10.3389/fpsyg.2018.01531
Abdulah DM, Abdulla BMO. Effectiveness of group art therapy on quality of life in paediatric patients with cancer: a randomized controlled trial. Compl Ther Med. 2018;41:180-185. https://doi.org/10.1016/j.ctim.2018.09.020
Boehm K, Cramer H, Staroszynski T, Ostermann T. Arts therapies for anxiety, depression, and quality of life in breast cancer patients: a systematic review and meta-analysis. Evid Based Complement Alternat Med. 2014;2014:1-9. https://doi.org/10.1155/2014/103297
Puetz TW, Morley CA, Herring MP. Effects of creative arts therapies on psychological symptoms and quality of life in patients with cancer. JAMA Intern Med. 2013;173(11):960. https://doi.org/10.1001/jamainternmed.2013.836
Bar-Sela G, Atid L, Danos S, Gabay N, Epelbaum R. Art therapy improved depression and influenced fatigue levels in cancer patients on chemotherapy. Psycho Oncol. 2007;16(11):980-984. https://doi.org/10.1002/pon.1175
Yellen SB, Cella DF, Webster K, Blendowski C, Kaplan E. Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system. J Pain Symptom Manag. 1997;13(2):63-74. https://doi.org/10.1016/s0885-3924(96)00274-6
Gentile S, Delarozière JC, Favre F, Sambuc R, San Marco JL. Validation of the French « multidimensional fatigue inventory » (MFI 20). Eur J Cancer Care. 2003;12(1):58-64. https://doi.org/10.1046/j.1365-2354.2003.00295.x
Flechtner H, Bottomley A. Fatigue and quality of life: lessons from the real world. Oncol. 2003;8(Suppl 1):5-9. https://doi.org/10.1634/theoncologist.8-suppl_1-5
Wratten C, Kilmurray J, Nash S, et al. Fatigue during breast radiotherapy and its relationship to biological factors. Int J Radiat Oncol. 2004;59(1):160-167. https://doi.org/10.1016/j.ijrobp.2003.10.008
Cella DF, Tulsky DS, Gray G, et al. The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. J Clin Oncol. 1993;11(3):570-579. https://doi.org/10.1200/jco.1993.11.3.570
Brady MJ, Cella DF, Mo F, et al. Reliability and validity of the functional assessment of cancer therapy-breast quality-of-life instrument. J Clin Oncol Off J Am Soc Clin Oncol. 1997;15(3):974-986. https://doi.org/10.1200/jco.1997.15.3.974
Webster K, Cella D, Yost K. The functional assessment of chronic illness therapy (FACIT) measurement system: properties, applications, and interpretation. Health Qual Life Outcome. 2003;1:79. https://doi.org/10.1186/1477-7525-1-79
Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67(6):361-370. https://doi.org/10.1111/j.1600-0447.1983.tb09716.x
De Feudis RL, Graziano G, Lanciano T, Garofoli M, Lisi A, Marzano N. An art therapy group intervention for cancer patients to counter distress before chemotherapy. Arts Health. 2019;13:1-14. https://doi.org/10.1080/17533015.2019.1608566
Puig A, Lee SM, Goodwin L, Sherrard PAD. The efficacy of creative arts therapies to enhance emotional expression, spirituality, and psychological well-being of newly diagnosed Stage I and Stage II breast cancer patients: a preliminary study. Arts Psychother. 2006;33(3):218-228. https://doi.org/10.1016/j.aip.2006.02.004
Monti DA, Peterson C, Kunkel EJS, et al. A randomized, controlled trial of mindfulness-based art therapy (MBAT) for women with cancer. Psycho Oncol. 2006;15(5):363-373. https://doi.org/10.1002/pon.988
Bozcuk H, Ozcan K, Erdogan C, Mutlu H, Demir M, Coskun S. A comparative study of art therapy in cancer patients receiving chemotherapy and improvement in quality of life by watercolor painting. Compl Ther Med. 2017;30:67-72. https://doi.org/10.1016/j.ctim.2016.11.006
Geue K, Goetze H, Buttstaedt M, Kleinert E, Richter D, Singer S. An overview of art therapy interventions for cancer patients and the results of research. Compl Ther Med. 2010;18(3-4):160-170. https://doi.org/10.1016/j.ctim.2010.04.001
Furmaniak AC, Menig M, Markes MH. Exercise for women receiving adjuvant therapy for breast cancer. Cochrane Database Syst Rev. 2016;9:CD005001. https://doi.org/10.1002/14651858.cd005001.pub3
Dong B, Xie C, Jing X, Lin L, Tian L. Yoga has a solid effect on cancer-related fatigue in patients with breast cancer: a meta-analysis. Breast Cancer Res Treat. 2019;177(1):5-16. https://doi.org/10.1007/s10549-019-05278-w
Bradt J, Shim M, Goodill SW. Dance/movement therapy for improving psychological and physical outcomes in cancer patients. Cochrane Database Syst Rev. 2015;1:CD007103. https://doi.org/10.1002/14651858.cd007103.pub3
Bradt J, Dileo C, Magill L, Teague A. Music interventions for improving psychological and physical outcomes in cancer patients Cochrane Gynaecological, Neuro-oncology and Orphan Cancer Group, éditeur. Cochrane Database Syst Rev. 2016. [Internet]. [cité 28 oct 2019]Disponible sur: http://doi.wiley.com/10.1002/14651858.CD006911.pub3
Joly F, Lange M, Dos Santos M, Vaz-Luis I, Di Meglio A. Long-Term fatigue and cognitive disorders in breast cancer survivors. Cancers. 2019;11(12):1896. https://doi.org/10.3390/cancers11121896
Svensk A-C, Öster I, Thyme KE, et al. Art therapy improves experienced quality of life among women undergoing treatment for breast cancer: a randomized controlled study. Eur J Cancer Care. 2009;18(1):69-77. https://doi.org/10.1111/j.1365-2354.2008.00952.x
Monti DA, Kash KM, Kunkel EJ, et al. Psychosocial benefits of a novel mindfulness intervention versus standard support in distressed women with breast cancer. Psycho Oncol. 2013;22(11):2565-2575. https://doi.org/10.1002/pon.3320
Wiswell S, Bell JG, McHale J, Elliott JO, Rath K, Clements A. The effect of art therapy on the quality of life in patients with a gynecologic cancer receiving chemotherapy. Gynecol Oncol. 2019;152(2):334-338. https://doi.org/10.1016/j.ygyno.2018.11.026

Auteurs

Florence Joly (F)

Department of Oncology, UNICANCER, Centre François Baclesse, Caen, France.
INSERM, U1086, Caen, France.
Université de Caen Basse-Normandie, UMR-S1077, Caen, France.
Department of Oncology, CHU de Caen, Caen, France.

David Pasquier (D)

UNICANCER, Centre Oscar Lambret, Lille, France.
Lille University, CRIStAL UMR, Lille, France.

Christelle Levy (C)

Department of Oncology, UNICANCER, Centre François Baclesse, Caen, France.

Mireille Mousseau (M)

Department of Oncology, CHU de Grenoble, Grenoble, France.

Marie-Christine D'Almeida (MC)

Department of Oncology, UNICANCER, Centre François Baclesse, Caen, France.

Sabine Noal (S)

Department of Oncology, UNICANCER, Centre François Baclesse, Caen, France.

Florence Le Tinier (F)

Department of Oncology, CHU de Grenoble, Grenoble, France.

Julien Geffrelot (J)

Department of Oncology, UNICANCER, Centre François Baclesse, Caen, France.

Catherine Ciais (C)

Department of Oncology, UNICANCER, Centre Antoine Lacassagne, Nice, France.

Viviane Szymczak (V)

UNICANCER, Centre Oscar Lambret, Lille, France.
Lille University, CRIStAL UMR, Lille, France.

Catherine Leon (C)

Department of Oncology, UNICANCER, Centre Henri Becquerel, Rouen, France.

Marie Pierre Rousselot (MP)

Department of Oncology, UNICANCER, Centre Antoine Lacassagne, Nice, France.

Stephanie Darbas (S)

Department of Oncology, CHU de Grenoble, Grenoble, France.

Chantal Hanzen (C)

Department of Oncology, UNICANCER, Centre Henri Becquerel, Rouen, France.

Natacha Heutte (N)

Department of Clinical Research, UNICANCER, Centre François Baclesse, Caen, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH